Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Jan;36(1):209–213. doi: 10.1128/aac.36.1.209

In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum.

L K Basco 1, J Le Bras 1
PMCID: PMC189259  PMID: 1590691

Abstract

The combinations of chloroquine plus chlorpromazine and chloroquine plus prochlorperazine were evaluated in vitro for potentiation against isolates of Plasmodium falciparum. Potentiation was observed against all chloroquine-resistant isolates. There was no potentiation against 8 of 10 chloroquine-susceptible isolates. The results indicated that the phenothiazines can potentiate chloroquine action against resistant parasites found in natural conditions.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basco L. K., Le Bras J. Reversal of chloroquine resistance with cyproheptadine in 'wild' strains of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):204–205. doi: 10.1016/0035-9203(91)90019-u. [DOI] [PubMed] [Google Scholar]
  2. Basco L. K., Le Bras J. Reversal of chloroquine resistance with desipramine in isolates of Plasmodium falciparum from Central and West Africa. Trans R Soc Trop Med Hyg. 1990 Jul-Aug;84(4):479–481. doi: 10.1016/0035-9203(90)90006-z. [DOI] [PubMed] [Google Scholar]
  3. Bitonti A. J., Sjoerdsma A., McCann P. P., Kyle D. E., Oduola A. M., Rossan R. N., Milhous W. K., Davidson D. E., Jr Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science. 1988 Dec 2;242(4883):1301–1303. doi: 10.1126/science.3057629. [DOI] [PubMed] [Google Scholar]
  4. Björkman A., Willcox M., Kihamia C. M., Mahikwano L. F., Howard P. A., Häkansson A., Warhurst D. Field study of cyproheptadine/chloroquine synergism in falciparum malaria. Lancet. 1990 Jul 7;336(8706):59–60. doi: 10.1016/0140-6736(90)91579-y. [DOI] [PubMed] [Google Scholar]
  5. Dahl S. G. Plasma level monitoring of antipsychotic drugs. Clinical utility. Clin Pharmacokinet. 1986 Jan-Feb;11(1):36–61. doi: 10.2165/00003088-198611010-00003. [DOI] [PubMed] [Google Scholar]
  6. Kyle D. E., Oduola A. M., Martin S. K., Milhous W. K. Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro. Trans R Soc Trop Med Hyg. 1990 Jul-Aug;84(4):474–478. doi: 10.1016/0035-9203(90)90004-x. [DOI] [PubMed] [Google Scholar]
  7. Le Bras J., Deloron P. In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test. Am J Trop Med Hyg. 1983 May;32(3):447–451. doi: 10.4269/ajtmh.1983.32.447. [DOI] [PubMed] [Google Scholar]
  8. Martin S. K., Oduola A. M., Milhous W. K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 1987 Feb 20;235(4791):899–901. doi: 10.1126/science.3544220. [DOI] [PubMed] [Google Scholar]
  9. Peters W., Ekong R., Robinson B. L., Warhurst D. C., Pan X. Q. Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum. Lancet. 1989 Aug 5;2(8658):334–335. doi: 10.1016/s0140-6736(89)90522-9. [DOI] [PubMed] [Google Scholar]
  10. Vandel S., Bertschy G., Nezeloff S., Bonin B., Volmat R. Tricyclic antidepressant plasma level monitoring: intraindividual variability in everyday practice. Eur J Clin Pharmacol. 1990;39(6):611–612. doi: 10.1007/BF00316109. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES